Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jonathan J. Geruntho"'
Autor:
Beatrice Langton-Webster, Charles M. Laymon, Brenda F. Kurland, Nathan Salamacha, Lora H. Rigatti, Hillarie P Windish, Jonathan J. Geruntho, Carolyn J. Anderson, Cindy J. Choy, Clifford E. Berkman, Ding Shen, Yijen L. Wu, Xiaoxi Ling, Joseph D. Latoche
Publikováno v:
Mol Imaging Biol
PURPOSE: Prostate-specific membrane antigen (PSMA) continues to be the hallmark biomarker for prostate cancer as it is expressed on nearly all prostatic tumors. In addition, increased PSMA expression correlates with castration resistance and progress
Autor:
Clifford E. Berkman, M. Grant Norton, Oscar Marin-Flores, Parissa Ziaei, Jonathan J. Geruntho
Publikováno v:
Journal of Materials Science. 52:6907-6916
Early diagnosis of prostate cancer and evaluation of appropriate treatment options requires development of effective and high-throughput selective capture technology for exosomes that are positive for the expression of enzyme-biomarker, prostate-spec
Autor:
Xiaoxi Ling, Clifford E. Berkman, Joseph D. Latoche, Jonathan J. Geruntho, Sophia K. Beyer, Beatrice Langton-Webster, Carolyn J. Anderson, Cindy J. Choy
Publikováno v:
Theranostics. 7:1928-1939
Prostate-specific membrane antigen (PSMA) continues to be an active biomarker for small-molecule PSMA-targeted imaging and therapeutic agents for prostate cancer and various non-prostatic tumors that are characterized by PSMA expression on their neov
Autor:
Henry F. VanBrocklin, Ella F. Jones, Christopher R. Drake, Hendry Cahaya, Sophia K. Beyer, Jonathan J. Geruntho, Shorouk Dannoon, Melanie Regan, Mark R. Hopkins, Lubica Skultetyova, Tanushree Ganguly, Salma Jivan, Cyril Barinka, Clifford E. Berkman, Cindy J. Choy, Matthew S. Galliher, Joseph E. Blecha
Publikováno v:
Journal of medicinal chemistry, vol 59, iss 12
A series of phosphoramidate-based prostate specific membrane antigen (PSMA) inhibitors of increasing lipophilicity were synthesized (4, 5, and 6), and their fluorine-18 analogs were evaluated for use as positron emission tomography (PET) imaging agen
Publikováno v:
Bioconjugate Chemistry. 27:824-830
We have developed a novel pH-sensitive linker based on a phosphoramidate scaffold that can be tuned to release amine-containing drug molecules at various pH values. The pH-triggered phosphoramidate-based linkers are responsive to pH alone and do not
Autor:
Clifford E. Berkman, Brian H. Clowers, Brian Scott Backer, Corinne Rose Ley, Cindy J. Choy, Jonathan J. Geruntho, Austen L. Davis
Publikováno v:
Bioconjugate chemistry. 27(9)
We developed a second generation of tunable pH-sensitive linkers based on our phosphoramidate scaffold to release amine-containing drugs under acidic conditions. The pH-triggered phosphoramidate-based linkers are responsive to pH and do not require i
Autor:
Robert A. Richards, Matthew A. Zuchero, Brittney L. Tiley, Stefan Stoll, Evan A. Welker, Wing-Sze Tong, Jeffrey P. Wolbach, Ian J. Rhile, Crina M. Sasaran, Melissa J. Vettleson, Jonathan J. Geruntho
Publikováno v:
The Journal of organic chemistry. 80(17)
Proton-coupled electron transfer (PCET) model systems combine one-electron oxidants and bases to generate net hydrogen atom acceptors. We have generated two persistent pyridyl-appended radical cations: 10-(pyrid-2-yl)-10H-phenothiazinium (PPT•+) an
Autor:
Lisa Y, Wu, Jacqueline M, Johnson, Jessica K, Simmons, Desiree E, Mendes, Jonathan J, Geruntho, Tiancheng, Liu, Wessel P, Dirksen, Thomas J, Rosol, William C, Davis, Clifford E, Berkman
Publikováno v:
The Prostate. 74(5)
Prostate-specific membrane antigen (PSMA) remains an important target for diagnostic and therapeutic application for human prostate cancer. Model cell lines have been recently developed to study canine prostate cancer but their PSMA expression and en